These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Bradyarrhythmia induced by amiodarone-sofosbuvir co-administration. Ghembaza Mel A; Lounici A Indian J Gastroenterol; 2016 Jul; 35(4):319-20. PubMed ID: 27481353 [No Abstract] [Full Text] [Related]
25. A case of amiodarone-associated pulmonary toxicity. Kwon KH; Jeong SW; Uh S; Kim YH; Jin SY; Park JS; Kang CH; Park CS Korean J Intern Med; 1995 Jul; 10(2):155-9. PubMed ID: 7495776 [TBL] [Abstract][Full Text] [Related]
26. [Amiodarone-induced immune complex cutaneous vasculitis]. Ndiaye M; Lebrun-Vignes B; Ortonne N; Fardet L Ann Dermatol Venereol; 2017 Dec; 144(12):788-792. PubMed ID: 28935425 [TBL] [Abstract][Full Text] [Related]
27. Phlebitis in Intravenous Amiodarone Administration: Incidence and Contributing Factors. Oragano CA; Patton D; Moore Z Crit Care Nurse; 2019 Feb; 39(1):e1-e12. PubMed ID: 30710042 [TBL] [Abstract][Full Text] [Related]
28. Amiodarone induced "Blue man syndrome"; an unusual presentation. Fishman TJ; Spencer S; Harrell R; Salabei JK Heart Lung; 2020; 49(2):202-203. PubMed ID: 31780190 [TBL] [Abstract][Full Text] [Related]
29. The incidence and predictors of overall adverse effects caused by low dose amiodarone in real-world clinical practice. Kim HL; Seo JB; Chung WY; Kim SH; Kim MA; Zo JH Korean J Intern Med; 2014 Sep; 29(5):588-96. PubMed ID: 25228834 [TBL] [Abstract][Full Text] [Related]
30. [Skin necrosis and consequences of accidental subcutaneous administration of amiodarone]. Grove EL Ugeskr Laeger; 2015 Jun; 177(24):. PubMed ID: 26058523 [No Abstract] [Full Text] [Related]
31. Amiodarone monitoring practices in pediatric hospitals in the United States. Moffett BS; Valdes SO; Kim JJ Pediatr Cardiol; 2013; 34(8):1762-6. PubMed ID: 23640245 [TBL] [Abstract][Full Text] [Related]
32. Amiodarone use and the risk of acute pancreatitis: Influence of different exposure definitions. Hempenius M; Groenwold RHH; de Boer A; Klungel OH; Gardarsdottir H Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1563-1571. PubMed ID: 31373736 [TBL] [Abstract][Full Text] [Related]
33. Using fractional polynomials to model the effect of cumulative duration of exposure on outcomes: applications to cohort and nested case-control designs. Austin PC; Park-Wyllie LY; Juurlink DN Pharmacoepidemiol Drug Saf; 2014 Aug; 23(8):819-29. PubMed ID: 24664670 [TBL] [Abstract][Full Text] [Related]